Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulp therapy with CTZ versus CZ antibiotic paste in primary molars
RBR-5w2fsx4Phase 3Recruiting
- Sponsor
- Universidade Federal do Piauí
- Start
- Jan 2025
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of chloramphenicol, tetracycline, zinc oxide and Eugenol in irreversible pulpitis and pulpal necrosis (2 arms), sponsored by Universidade Federal do Piauí. Started Jan 2025; status: recruiting.
02
Drugs
chloramphenicoltetracyclinezinc oxideEugenol
03
Conditions
irreversible pulpitispulpal necrosis
Beyond the preview
Go deeper on RBR-5w2fsx4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-5w2fsx4.